Parameswaran Hari Selected Research

Parameswaran Hari Research Topics

Disease

101	Multiple Myeloma 05/2024 - 09/2006
28	Neoplasms (Cancer) 03/2024 - 10/2009
18	Amyloidosis 01/2022 - 05/2009
13	Immunoglobulin Light-chain Amyloidosis 01/2021 - 05/2009
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2006
10	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 11/2011
7	Residual Neoplasm 05/2024 - 01/2016
7	Infections 08/2023 - 04/2009
7	Disease Progression 01/2020 - 12/2011
5	Plasma Cell Leukemia 01/2023 - 12/2020
5	Thrombocytopenia (Thrombopenia) 04/2021 - 07/2012
5	Lymphoma (Lymphomas) 01/2017 - 08/2008
4	Primary Myelofibrosis (Myelosclerosis) 09/2022 - 08/2012
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020 - 10/2016
3	Chromosome Aberrations (Chromosome Abnormalities) 04/2024 - 09/2007
3	Paraproteinemias (Monoclonal Gammopathy) 03/2024 - 11/2010
3	Obesity 01/2019 - 12/2011
3	Neutropenia 01/2019 - 07/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2007
3	Heart Failure 11/2014 - 05/2009
2	Abdominal Obesity 01/2024 - 09/2023
2	Viremia 08/2023 - 12/2020
2	Splenomegaly 09/2022 - 08/2012
2	Diarrhea 10/2021 - 01/2017
2	Thrombosis (Thrombus) 04/2021 - 05/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2020 - 01/2020
2	Pneumonia (Pneumonitis) 11/2017 - 07/2012
1	Monoclonal Gammopathy of Undetermined Significance 03/2024
1	Virus Diseases (Viral Diseases) 11/2023
1	Melanoma (Melanoma, Malignant) 12/2022
1	cell-associated neurotoxicity 01/2022

Drug/Important Bio-Agent (IBA)

18	Lenalidomide (CC 5013)FDA Link 05/2024 - 05/2012
17	Proteasome InhibitorsIBA 01/2023 - 12/2014
16	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 05/2012
15	Bortezomib (Velcade)FDA Link 11/2023 - 01/2006
13	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2019
11	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 12/2011
8	trans-crotonin (CTN)IBA 01/2024 - 12/2011
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 05/2012
8	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2011
7	B-Cell Maturation AntigenIBA 11/2023 - 01/2020
7	Monoclonal AntibodiesIBA 01/2022 - 12/2013
6	ixazomibIBA 01/2023 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2015
5	daratumumabIBA 04/2024 - 01/2019
5	Immunoglobulins (Immunoglobulin)IBA 02/2022 - 01/2018
5	fludarabineIBA 01/2021 - 09/2013
5	Amyloid (Amyloid Fibrils)IBA 06/2018 - 10/2010
4	carfilzomibIBA 11/2023 - 01/2018
3	tocilizumab (atlizumab)FDA Link 01/2023 - 12/2011
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 05/2018
3	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2022 - 12/2015
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 10/2014
3	Busulfan (Busulfex)FDA Link 12/2020 - 01/2016
3	SteroidsIBA 01/2020 - 12/2011
3	Immunomodulating AgentsIBA 01/2020 - 09/2013
3	Tacrolimus (Prograf)FDA LinkGeneric 03/2019 - 10/2014
3	VaccinesIBA 12/2017 - 12/2013
2	Antiviral Agents (Antivirals)IBA 08/2023 - 12/2020
2	Single-Domain AntibodiesIBA 12/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2018
2	pembrolizumabIBA 10/2021 - 01/2019
2	AntibodiesIBA 04/2021 - 01/2016
2	Heparin (Liquaemin)FDA LinkGeneric 04/2021 - 05/2018
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 10/2014
2	Clofarabine (Clolar)FDA Link 01/2021 - 07/2012
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 10/2016
2	isatuximabIBA 12/2020 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2020 - 10/2015
2	CytokinesIBA 01/2020 - 01/2006
2	plerixafor FDA Link 12/2019 - 10/2016
2	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 01/2018
2	ONX 0912IBA 01/2019 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017 - 12/2011
2	ruxolitinibIBA 01/2016 - 08/2012
2	Everolimus FDA Link 03/2015 - 08/2014
2	GadoliniumIBA 11/2014 - 05/2009
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2012 - 11/2010
2	Congo RedIBA 01/2011 - 10/2010
1	Adenosine Monophosphate (AMP)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	phytobacteriomycin (PBM)IBA 03/2024
1	Immune Checkpoint InhibitorsIBA 12/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	idecabtagene vicleucelIBA 01/2022

Therapy/Procedure

65	Therapeutics 04/2024 - 09/2006
51	Cell Transplantation 05/2024 - 04/2009
15	Transplantation 01/2021 - 09/2006
13	Hematopoietic Stem Cell Transplantation 12/2020 - 02/2007
11	Stem Cell Transplantation 10/2021 - 09/2006
9	Autologous Transplantation 01/2019 - 10/2008
8	Drug Therapy (Chemotherapy) 01/2020 - 02/2007
7	Immunotherapy 01/2022 - 01/2016
5	Homologous Transplantation 12/2023 - 04/2009
3	Aftercare (After-Treatment) 11/2023 - 10/2015
2	Withholding Treatment 11/2023 - 01/2022
2	Duration of Therapy 11/2023 - 01/2018
2	Induction Chemotherapy 01/2021 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2022
1	Splenectomy 09/2022